The effect of impacted allogenic chip bone graft usage for noncontained type bone defect in primary or revision TKA

Author(s): Hyung Gyu Cho, Chang Hyun Shin, Churl-Hong Chun

Abstract

We assessed the clinical and radiological results of using chip bone graft in non-contained type bone defect in primary or revision TKA patients. We investigated 32 patients (5 males and 27 females) underwent primary or revision TKA from March 2014 to February 2017, with non-contained type of defect. The mean age was 73.1 years. 7 were primary TKA patients, while 25 were revision patients. 8 had chip bone graft used both in the femur and tibia, 9 only in the tibia, and the other 15 only in the femur.

Share this article